S&P 500

5.996,66

1,00%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Aspira Womans Health Inc (AWH)
Aspira Womans Health Inc (AWH) Notícias

AWH

Aspira Womans Health (AWH)

Aspira Womans Health Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:AWH

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
08/01/2025	21:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AWH	Aspira Womans Health Inc
08/01/2025	19:30	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:AWH	Aspira Womans Health Inc
07/01/2025	18:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AWH	Aspira Womans Health Inc
16/12/2024	10:45	GlobeNewswire Inc.	Aspira Women’s Health Announces Appointment of Dr. Sandra Milligan as Interim CEO	NASDAQ:AWH	Aspira Womans Health Inc
03/12/2024	10:00	GlobeNewswire Inc.	Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award	NASDAQ:AWH	Aspira Womans Health Inc
22/11/2024	20:16	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:AWH	Aspira Womans Health Inc
19/11/2024	18:35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AWH	Aspira Womans Health Inc
14/11/2024	18:00	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:AWH	Aspira Womans Health Inc
14/11/2024	17:23	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:AWH	Aspira Womans Health Inc
14/11/2024	10:00	GlobeNewswire Inc.	Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results	NASDAQ:AWH	Aspira Womans Health Inc
07/11/2024	10:00	GlobeNewswire Inc.	Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®	NASDAQ:AWH	Aspira Womans Health Inc
04/11/2024	10:00	GlobeNewswire Inc.	Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024	NASDAQ:AWH	Aspira Womans Health Inc
25/10/2024	09:00	GlobeNewswire Inc.	Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024	NASDAQ:AWH	Aspira Womans Health Inc
23/10/2024	12:23	GlobeNewswire Inc.	Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health	NASDAQ:AWH	Aspira Womans Health Inc
15/10/2024	17:05	GlobeNewswire Inc.	Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch®	NASDAQ:AWH	Aspira Womans Health Inc
10/09/2024	09:00	GlobeNewswire Inc.	Aspira Women’s Health Announces Publication of Data Demonstrating Performance of its In-Development Blood Test for the Assessment of Malignancy Risk in Patients with an Adnexal Mass	NASDAQ:AWH	Aspira Womans Health Inc
06/09/2024	09:00	GlobeNewswire Inc.	Aspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:AWH	Aspira Womans Health Inc
05/09/2024	17:02	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:AWH	Aspira Womans Health Inc
05/09/2024	09:00	GlobeNewswire Inc.	Aspira Women’s Health Selected as a Spoke for the Investor Catalyst Hub	NASDAQ:AWH	Aspira Womans Health Inc
04/09/2024	01:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:AWH	Aspira Womans Health Inc
27/08/2024	09:00	GlobeNewswire Inc.	Aspira Women’s Health Partners with Dorsata to Create New Clinical Workflow Tool for Adnexal Masses	NASDAQ:AWH	Aspira Womans Health Inc
23/08/2024	17:00	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:AWH	Aspira Womans Health Inc
22/08/2024	08:14	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AWH	Aspira Womans Health Inc
20/08/2024	18:00	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AWH	Aspira Womans Health Inc
12/08/2024	17:05	GlobeNewswire Inc.	Aspira Women’s Health Reports Second Quarter 2024 Financial Results	NASDAQ:AWH	Aspira Womans Health Inc
05/08/2024	09:37	GlobeNewswire Inc.	Aspira Women’s Health’s Announces a Poster Presentation at the 27th Annual National Association of Nurse Practitioners in Women’s Health (NPWH) Women’s Healthcare Conference	NASDAQ:AWH	Aspira Womans Health Inc
02/08/2024	18:26	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:AWH	Aspira Womans Health Inc
01/08/2024	09:00	GlobeNewswire Inc.	Aspira Women’s Health Announces Poster Presentation at the Menopause Society’s 2024 Annual Meeting	NASDAQ:AWH	Aspira Womans Health Inc
31/07/2024	17:05	GlobeNewswire Inc.	Aspira Women’s Health to Announce Second Quarter Earnings Results and Host a Conference Call on Monday, August 12	NASDAQ:AWH	Aspira Womans Health Inc
29/07/2024	10:00	GlobeNewswire Inc.	Aspira Women’s Health Appoints Mr. John Ragard to its Board of Directors	NASDAQ:AWH	Aspira Womans Health Inc